
Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, highlights several potential strategies to address the historic lack of diversity in multiple myeloma clinical trial populations.

Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, highlights several potential strategies to address the historic lack of diversity in multiple myeloma clinical trial populations.

Researchers found that human papillomavirus (HPV) awareness was highest among liberals, who were also most likely to be aware of HPV vaccines compared with individuals who reported moderate and conservative ideologies.

A retrospective analysis of the CARTITUDE-1 trial suggests that patients who have undergone allogeneic stem cell transplant (allo-SCT) prior to receiving chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma experience comparable outcomes to allo-SCT–naïve patients.

Investigators said analysis of multiple tissues from the same patients suggests tumor evolution in high-grade serous ovarian cancer (HGSC) was not through somatic mutations.

With the decision, ClarityPro becomes the first and only device to offer new technology add-on payment reimbursement for the diagnosis of electrographic status epilepticus.

Proper implementation of oxygen therapy within patients with interstitial lung disease (ILD) requires the strengthening of international guidelines, improved oxygen delivery systems, and equitable funding models.

Combination endoscopic sinus surgery (ESS) and biological therapy significantly decreased polyp burden in refractory chronic rhinosinusitis with nasal polyposis (CRSwNP) compared with biologic therapy alone

Javed Butler, MD, MPH, MBA, said "hopefully" results from the EMPACT-MI trial should be available within the next few months.

Three sessions of a semi-structured focus group were conducted to gain patient feedback on personalized screening for colorectal cancer (CRC).

Tariq Cheema, MD, division chair of pulmonary critical care sleep and allergy medicine at Allegheny Health Network (AHN), discusses how the virtual ICU (vICU) program has improved access to patient care.

Administering extended half-life respiratory syncytial virus (RSV) antibodies in the newborn nursery would minimize access disparities and ensure optimal uptake, study authors posited.

Periodic limb movements during sleep (PLMS) are an added risk factor for cardiovascular disease in obstructive sleep apnea (OSA), recent study findings suggest.

The study comprehensively described the atopic dermatitis (AD) burden among young Japanese patients with moderate or severe forms of the disease.

Understanding the barriers experienced by older adults using mobile health tools highlights key areas for improvement and research efforts in telehealth.

Teriflunomide treatment incurred an unadjusted risk reduction of 63% and an adjusted risk reduction of 72% in inhibiting a first clinical demyelinating event in patients with multiple sclerosis (MS).

CDC outlines new procedures for sepsis response; mask mandates resurface during COVID-19 increase; a recent study shows that technology can help support public health programs.

MRI screening shows promise for predicting clinically significant prostate cancer (PCa) early on and independently of prostate-specific antigen (PSA) assessment.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The FDA has approved the first biosimilar to treat multiple sclerosis, Sandoz's injection treatment natalizumab-sztn (Tyruko).

Catherine Nester, RN, vice president of physician and patient strategies at Inozyme Pharma, highlights the importance of newborn screening for rare diseases and the impact of the BeginNGS diagnostic tool.

Patients who took the therapy lost weight and recorded some of the best gains in quality of life and physical improvement ever seen in this type of a study.

The interim update in heart failure reflects results from 10 clinical trials that have been published since the 2021 ESC Guidelines were released.

Second-line treatment with axicabtagene ciloleucel (axi-cel) led to an investigator-assessed, 3-month complete metabolic response rate of 71.0% in patients with large B-cell lymphoma (LBCL) who were ineligible for autologous stem cell transplant.

Researchers investigated methods for measuring prior exposure in patients with suspected, undocumented COVID-19 infection to give better access to care and counsel.

Lucio Gordan, MD, president and managing physician, Florida Cancer Specialists & Research Institute (FCS), discusses how FCS has learned to adapt during difficult times, including COVID-19, Hurricane Ian, and current drug shortages.

Results reveal living in neighborhoods with very high Childhood Opportunity Index (COI) scores is linked with elevated odds of being up to date on preventive visits and immunizations when compared with those living in neighborhoods with very low COI scores.

The risk of developing chronic obstructive pulmonary disease (COPD) increased in young people who smoke cigarettes more frequently, indicating smoking is an important COPD risk factor.

The Biden administration is expected to unveil the first 10 drugs identified for drug price negotiations Tuesday; American nursing homes are disappearing; gender-affirming surgeries tripled in the United States between 2016-2019.

Hidradenitis suppurativa (HS) contributes to an extensive weakening in work ability and productivity, as well as large loss of gross value added.

In 2023, the United States was in the midst of the largest drug shortage in a decade, including lifesaving platinum-based medications to treat a variety of cancers.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
